Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;126(4):793-797.
doi: 10.1002/jso.26976. Epub 2022 Jun 7.

Synovial sarcomas: A single surgeon experience of 130 cases

Lorenzo Andreani  1 , Edoardo Ipponi  1 , Olimpia Mani  1 , Ginevra Bayon  1 , Alfio Damiano Ruinato  1 , Fabio Cosseddu  1 , Antonio D'Arienzo  1 , Rodolfo Capanna  1
Affiliations

Synovial sarcomas: A single surgeon experience of 130 cases

Lorenzo Andreani et al. J Surg Oncol. 2022 Sep.

Abstract

Background: Synovial sarcoma is a rare malignant tumor that generally requires a multidisciplinary therapeutic approach. In this study we report the experience of a single surgeon, evaluating surgical and oncological outcomes of the cases he treated through his 30 years carrier.

Methods: We enrolled patients treated surgically between 1988 and 2018. Surgical and medical treatments, as well as surgical and oncological results, were investigated.

Results: One hundred and thirty cases were included. Surgical resection was carried out achieving wide margins in 90% of the cases. At their latest follow-up, 76 patients were continuously disease free, 16 were no evidence of disease, and other 16 were alive with disease. Twenty cases were dead of disease and two dead of other causes. Twenty-five patients (19%) had local recurrence of synovial sarcoma through their postoperative intercourse. Thirty-seven patients (28%) were diagnosed with at least a metastasis during their follow-up. The global survival of our population, at each patient's latest follow-up, was 82%. Cases with tumor size above 5 cm had a significantly higher risk to develop metastasis (p = 0.002).

Conclusions: Synovial sarcoma is a threatening disease and represents a challenge for oncological physicians and surgeons. Early diagnosis and multidisciplinary approach are mandatory to limit the spread of synovial sarcomas, maximizing the effectiveness of surgery and the other treatments.

Keywords: oncological surgery; survival; synovial sarcoma; tumor resection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Magnetic resonance images of a wide synovial sarcoma localized in the thigh.
Figure 2
Figure 2
Local recurrence‐free over time according to whether the excision was marginal or wide.
See this image and copyright information in PMC

References

    1. Rajwanshi A, Srinivas R, Upasana G. Malignant small round cell tumors. J Cytol. 2009;26:1‐10. - PMC - PubMed
    1. Skubitz KM, D'Adamo DR. Sarcoma. Mayo Clin Proc. 2007;82(11):1409‐1432. - PubMed
    1. Aytekin MN, Öztürk R, Amer K, Yapar A. Epidemiology, incidence, and survival of synovial sarcoma subtypes: SEER database analysis. J Orthop Surg (Hong Kong). 2020;28(2):2309499020936009. - PubMed
    1. Clark J, Rocques PJ, Crew AJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994;7:502‐508. - PubMed
    1. Crew AJ, Clark J, Fisher C, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel associated box in human synovial sarcoma. EMBO J. 1995;14:2333‐2340. - PMC - PubMed